INVO Bioscience, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by INVO Bioscience, Inc. (trading symbol: INVO) on April 13, 2021, covering events occurring on April 9, 2021. The company is incorporated in Nevada and operates on the Nasdaq Stock Market. The filing primarily addresses the entry into a material definitive agreement to expand its clinical footprint.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a contractual agreement rather than periodic financial performance data.
Material Changes and Agreements
- Partnership Agreement: On April 9, 2021, the Company entered into a Partnership Agreement with Lyfe Medical Center I, LLC ("Medical Center").
- New Clinic: The agreement establishes a clinic in Santa Cruz, California (the "Cruz Clinic") to offer the INVO Procedure.
- Service Scope: INVO Bioscience will provide embryology laboratory services ("Lab Services") in connection with the INVO Procedure and other fertility treatments at the Cruz Clinic.
- Revenue Model: Under the agreement, the Company will receive 40% of the net income received by the Cruz Clinic specifically for the performance of the Lab Services.
- Strategic Shift: The Company previously announced an intent in early 2019 to establish a similar partnership in the San Francisco area with a different partner. That initiative was discontinued to focus resources on the new partnership with Medical Center for the region.
Guidance, Outlook, and Risks
The filing does not contain forward-looking financial guidance, management commentary on future earnings, or specific risk factors beyond the standard disclaimer that the summary of the Partnership Agreement is qualified by the full text of the agreement filed as Exhibit 10.1.
Investor Verification Checklist
- Review the full text of the Partnership Agreement (Exhibit 10.1) to understand termination clauses, exclusivity terms, and operational responsibilities.
- Verify the timeline for the opening of the Cruz Clinic in Santa Cruz, California.
- Assess the financial impact of the 40% net income share on future revenue streams once the clinic becomes operational.
- Confirm the regulatory status of the INVO Procedure in California and any specific licensing requirements for the new clinic.